Friday, April 19, 2024

TOPICS

Home Tags Rubius Therapeutics

Tag: Rubius Therapeutics

Rubius Therapeutics added to Nasdaq biotechnology index

SMITHFIELD – Biotechnology firm Rubius Therapeutics Inc. was added to the Nasdaq biotechnology index on Dec. 24. The company, based in Cambridge, Mass., but building...
RUBIUS THERAPEUTICS reported a $26.4 million loss for the third quarter. The company does not yet generate revenue.

Rubius reports $26.4M loss for Q3

PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...
PBN PHOTO/MIKE SKORSKI

Most-read stories on PBN.com, July 2018

1. 2018 40 Under Forty winners feted at Aldrich Mansion POSTED ONLINE: JULY 20. A record crowd of 475 took the occasion of a...

Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield

SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...

Rebuild Rhode Island tax credit program surpasses $100M mark

PROVIDENCE – The state’s Rebuild Rhode Island tax credit program recently exceeded the $100 million mark with last month’s award to Rubius Therapeutics Inc. The...

BBJ: Rubius Therapeutics raises $241M in IPO, highest for biotech company...

PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts...

Most read stories on PBN.com, June 2018

1. 2018 40 under Forty winners chosen POSTED ONLINE: JUNE 8. Providence Business News has chosen the winners for its 14th 40 Under Forty program,...

Smart incentives help seal deal

Certainly it was good news when Rubius Therapeutics Inc. announced its intention to open a pharmaceutical manufacturing facility in Rhode Island. It didn’t have to...
RUBIUS THERAPEUTICS was approved for a potential $9 million in tax incentives by the R.I. Commerce Corp. Thursday. The company plans to retrofit a Smithfield manufacturing facility through a $155 million investment.

Biotech firm Rubius Therapeutics gains state incentives, will open new plant

PROVIDENCE – R.I. Commerce Corp., the state’s economic development agency, on Thursday approved a package of tax reductions and incentives potentially worth more than...

Cambridge biotech Rubius Therapeutics considers R.I. for pharmaceutical manufacturing facility

PROVIDENCE – A Cambridge, Mass.-based biotech company may build a $155 million pharmaceutical manufacturing facility in Rhode Island, and is seeking state incentives from...
- Featured Event -

Latest News